Metabolex takes $8.6M to treat diabetes

November 9, 2009 | Camille Ricketts | Comments |
|

Metabolex, maker of treatments for Type 2 diabetes, has raised $8.6 million in a fifth round of funding to fund trials on its newest product. Based in Hayward, Calif., the company is backed by Alta Partners, Bay City Capital, Birchmere Ventures, Charter Ventures, Merlin Biomed, Novo Ventures, Next Chapter Holdings, VantagePoint Venture Partners, Venrock and Versant Ventures.

Next Story:
Previous Story:

Email
Print
Bookmark
Google
Delicious
Facebook
Twitter
StumbleUpon
MySpace
Digg
Live
More…

Tags: , , , , , , , , ,

Photo of Camille Ricketts

About the Author, Camille Ricketts

Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.

blog comments powered by Disqus